FWIW I have previuosly posted that I think pocketscripts gets 1-2 dollars a share in cash for Zix in an asset sale. That is 50-100 million dollars into the company coffers from an acquirer like Mckesson, IBM, Siemens, WebMD or another? This is a large premium over the purchase price. Anything over this price IMO would be the result of a 'bidding war' between two very interested parties. This could happen IMO, particlurly if the landscape grab as simp describes goes well for zix. The asett sale is necessary as the process to take pocketscripts to profitablility is very capital rich as the second article about consolidation that simp earlier posted discusses. All IMO.
It's silly to guess any dollar amount at this point. If they can get Aetna to the point of an expansion (regional or national) while continuing to be the sole-source vendor or prefered vendor, do the same with a few large-state Blues, and continue to show their deployment model works and can scale to 8,000 docs per quater, we won't be looking at a few bucks. It's a lot of ifs, but many of those glasses are more than half full.